V3-mediated neutralization of primary isolates.: Serology with synthetic V3 peptides demonstrates deficiencies in anti-V3 response

被引:0
|
作者
Pipkorn, R [1 ]
Lawoko, A [1 ]
Johansson, B [1 ]
Christenson, B [1 ]
Ljungberg, B [1 ]
Dietrich, U [1 ]
Alkhalili, L [1 ]
Fenyö, EM [1 ]
Blomberg, J [1 ]
机构
[1] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:793 / 794
页数:2
相关论文
共 50 条
  • [41] Induction of neutralizing antibodies in rhesus macaques using V3 mimotope peptides
    Hessell, Ann J.
    McBurney, Sean
    Pandey, Shilpi
    Sutton, William
    Liu, Lily
    Li, Liuzhe
    Totrov, Maxim
    Zolla-Pazner, Susan
    Haigwood, Nancy L.
    Gorny, Miroslaw K.
    VACCINE, 2016, 34 (24) : 2713 - 2721
  • [42] Fine specificity of anti-V3 antibodies induced in chimpanzees by HIV candidate vaccines
    Coëffier, E
    Girard, M
    Barré-Sinoussi, F
    Meignier, B
    Muchmore, E
    Fultz, PN
    LeClerc, C
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (12) : 1023 - 1034
  • [43] CONTINUITY AND DISCONTINUITY IN THE ANTI-V3 IMMUNOGLOBULIN-G RESPONSE OF HIV-1-INFECTED INDIVIDUALS IN A CROSS-SECTIONAL AND LONGITUDINAL-STUDY WITH SYNTHETIC PEPTIDES
    LAWOKO, A
    JOHANSSON, B
    FALCK, L
    DIETRICH, U
    PIPKORN, R
    NILEHN, B
    BLOMBERG, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S149 - S149
  • [44] Restricted specificity of anti-V3 antibodies induced in humans by HIV candidate vaccines
    Coeffier, E
    Excler, JL
    Kieny, MP
    Meignier, B
    Moste, C
    Tartaglia, J
    Pialoux, G
    SalmonCeron, D
    Leclerc, C
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (17) : 1471 - 1485
  • [45] Multivalent RGD synthetic peptides as potent αVβ3 integrin ligands
    Garanger, E
    Boturyn, D
    Coll, JL
    Favrot, MC
    Dumy, P
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2006, 4 (10) : 1958 - 1965
  • [46] Conformational Epitope Consisting of the V3 and V4 Loops as a Target for Potent and Broad Neutralization of Simian Immunodeficiency Viruses
    Kuwata, Takeo
    Takaki, Kaori
    Yoshimura, Kazuhisa
    Enomoto, Ikumi
    Wu, Fan
    Ourmanov, Ilnour
    Hirsch, Vanessa M.
    Yokoyama, Masaru
    Sato, Hironori
    Matsushita, Shuzo
    JOURNAL OF VIROLOGY, 2013, 87 (10) : 5424 - 5436
  • [47] PEPTIDE SEROLOGY FOR ANALYSIS OF THE INTERINDIVIDUAL AND INTRAINDIVIDUAL VARIATION IN THE HIV-1 V3 DOMAIN
    JANSSON, M
    WAHREN, B
    ALBERT, J
    SCARLATTI, G
    FRANZEN, L
    KATAAHA, PK
    KATABIRA, E
    MUBIRO, F
    WIGZELL, H
    ROSSI, P
    AIDS, 1994, 8 (04) : 413 - 421
  • [48] Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency
    Jacob, Rajesh Abraham
    Moyo, Thandeka
    Schomaker, Michael
    Abrahams, Fatima
    Pujol, Berta Grau
    Dorfman, Jeffrey R.
    JOURNAL OF VIROLOGY, 2015, 89 (10) : 5264 - 5275
  • [49] Optimization of the V3 Directed Antibody Response: Strategies to Expose the Epitope
    Moseri, A.
    Subramanyam
    Sagi, Y.
    Arshava, B.
    Naider, F.
    Anglister, J.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : A44 - A44
  • [50] NEUTRALIZATION OF DIVERSE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS BY AN ANTI-V3 HUMAN MONOCLONAL-ANTIBODY
    GORNY, MK
    CONLEY, AJ
    KARWOWSKA, S
    BUCHBINDER, A
    XU, JY
    EMINI, EA
    KOENIG, S
    ZOLLAPAZNER, S
    JOURNAL OF VIROLOGY, 1992, 66 (12) : 7538 - 7542